Literature DB >> 12889222

Assessment of disease severity and prognosis.

T A Medsger1, S Bombardieri, L Czirjak, R Scorza, A Della Rossa, W Bencivelli.   

Abstract

The Subcommittee members initially agreed on the concepts of disease activity, damage and severity, defining severity as the total effect of disease on organ function. It was decided to start with the assessment of severity using the Medsger's severity scale. A revised version of this scale was constructed. The rationale for the exclusion of other variables was provided.

Mesh:

Year:  2003        PMID: 12889222

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  111 in total

1.  Very low levels of vitamin D in systemic sclerosis patients.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2010-05-09       Impact factor: 2.980

2.  Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin.

Authors:  Raffaele De Palma; Francesco Del Galdo; Salvatore Lupoli; Paolo Altucci; Gianfranco Abbate; Gabriele Valentini
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

3.  What does the clinician need to improve patient care in systemic sclerosis?

Authors:  Madelon C Vonk; Frank H J van den Hoogen; Piet L C M van Riel; Gabriele Valentini
Journal:  Ann Rheum Dis       Date:  2007-09       Impact factor: 19.103

4.  Radiological hand involvement in systemic sclerosis.

Authors:  J Avouac; H Guerini; J Wipff; N Assous; A Chevrot; A Kahan; Y Allanore
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

5.  Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.

Authors:  Noreen Fertig; Robyn T Domsic; Tatiana Rodriguez-Reyna; Masataka Kuwana; Mary Lucas; Thomas A Medsger; Carol A Feghali-Bostwick
Journal:  Arthritis Rheum       Date:  2009-07-15

6.  Oropharyngolaryngeal disorders in scleroderma: development and validation of the SLS scale.

Authors:  Chiara Vitali; Elisa Borghi; Arianna Napoletano; Francesca Polini; Monica Caronni; Paola Ammenti; Davide Cattaneo
Journal:  Dysphagia       Date:  2009-08-26       Impact factor: 3.438

7.  Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?

Authors:  Mislav Radić; Dušanka Martinović Kaliterna; Damir Bonacin; Jadranka Morović Vergles; Josipa Radić; Damir Fabijanić; Vedran Kovačić
Journal:  Rheumatol Int       Date:  2012-12-06       Impact factor: 2.631

8.  Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire.

Authors:  Brittany L Adler; James W Russell; Laura K Hummers; Zsuzsanna H McMahan
Journal:  J Rheumatol       Date:  2018-06-15       Impact factor: 4.666

9.  Learning a Severity Score for Sepsis: A Novel Approach based on Clinical Comparisons.

Authors:  Kirill Dyagilev; Suchi Saria
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

10.  The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Authors:  Brooke Levis; Linda Kwakkenbos; Marie Hudson; Murray Baron; Brett D Thombs
Journal:  Clin Rheumatol       Date:  2016-12-10       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.